View in EDS HTML Full Text PDF Full Text

Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).

Saved in:
Bibliographic Details
Title: Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).
Authors: Podgorica M; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Drivet E; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Vestbøstad J; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Kvam AK; Department of Haematology, Oslo University Hospital, Norway., Wik HS; Department of Haematology, Oslo University Hospital, Norway., Munthe L; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Schjerven H; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Department of Laboratory Medicine, University of California San Francisco, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2311-2315. Date of Electronic Publication: 2025 Jul 29.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40728071
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Podgorica+M%22">Podgorica M</searchLink>; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Drivet+E%22">Drivet E</searchLink>; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Vestbøstad+J%22">Vestbøstad J</searchLink>; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kvam+AK%22">Kvam AK</searchLink>; Department of Haematology, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Wik+HS%22">Wik HS</searchLink>; Department of Haematology, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Munthe+L%22">Munthe L</searchLink>; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Schjerven+H%22">Schjerven H</searchLink>; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Department of Laboratory Medicine, University of California San Francisco, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2311-2315. <i>Date of Electronic Publication: </i>2025 Jul 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40728071
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2536125
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2311
    Titles:
      – TitleFull: Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Podgorica M
      – PersonEntity:
          Name:
            NameFull: Drivet E
      – PersonEntity:
          Name:
            NameFull: Vestbøstad J
      – PersonEntity:
          Name:
            NameFull: Kvam AK
      – PersonEntity:
          Name:
            NameFull: Wik HS
      – PersonEntity:
          Name:
            NameFull: Munthe L
      – PersonEntity:
          Name:
            NameFull: Schjerven H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1